Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07574632
A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.Nemours Children's HospitalNot Yet RecruitingNot Applicable
NCT07574632Not Yet Recruiting
Not Applicable
A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works,...Nemours Children's Hospit...
NCT07576465
Effects of SBMT Combined With NMES on UL Functions in Post Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07576465Recruiting
Not Applicable
Effects of SBMT Combined With NMES on UL Functions in Post Stroke PatientsRiphah International Univ...
NCT07575386
The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and Mental Well-Being in Individuals With Breast CancerEge UniversityNot Yet RecruitingNot Applicable
NCT07575386Not Yet Recruiting
Not Applicable
The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and...Ege University
NCT07574918
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin MedicalNot Yet RecruitingNot Applicable
NCT07574918Not Yet Recruiting
Not Applicable
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin Medical
NCT07576582
Peloid Therapy in Temporomandibular Joint DysfunctionUşak UniversityRecruitingNot Applicable
NCT07576582Recruiting
Not Applicable
Peloid Therapy in Temporomandibular Joint DysfunctionUşak University
NCT07574515
The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Randomized Controlled TrialLinkoeping UniversityNot Yet RecruitingNot Applicable
NCT07574515Not Yet Recruiting
Not Applicable
The Effect of Nasogastric Tube Placement on Complications in Patients With Small...Linkoeping University
NCT07574827
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private UniversityRecruiting
NCT07574827Recruiting
—
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private Univers...
NCT07575646
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel EtchingCairo UniversityNot Yet RecruitingNot Applicable
NCT07575646Not Yet Recruiting
Not Applicable
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective...Cairo University
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07575659
Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental TherapyTuba Derya DoğanNot Yet RecruitingNot Applicable
NCT07575659Not Yet Recruiting
Not Applicable
Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Th...Tuba Derya Doğan
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07576322
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University Hospitals, SwitzerlandNot Yet RecruitingNot Applicable
NCT07576322Not Yet Recruiting
Not Applicable
Short-Term Safety and Performance of Two Wound Dressings EvaluationCHUV, Lausanne University...
NCT07575750
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double BlindInstitut Cancerologie de l'OuestNot Yet RecruitingNot Applicable
NCT07575750Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatas...Institut Cancerologie de...
NCT07575022
Computer Assisted Navigation on Endoscopic Sinus Surgery for Treatment of Sinonasal PolyposisAl-Azhar UniversityCompleted
NCT07575022Completed
—
Computer Assisted Navigation on Endoscopic Sinus Surgery for Treatment of Sinona...Al-Azhar University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575295
A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventive Coagulation for Intraprocedural Vessel Management During Peroral Endoscopic Myotomy (POEM)Asian Institute of Gastroenterology, IndiaRecruiting
NCT07575295Recruiting
—
A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventiv...Asian Institute of Gastro...
NCT07575984
Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic StrokePharmasoftRecruitingPhase 4
NCT07575984Recruiting
Phase 4
Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Strok...Pharmasoft
NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)AmgenNot Yet RecruitingPhase 3
NCT07575399Not Yet Recruiting
Phase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Rece...Amgen
Result Breakdown
Not yet recruiting11 (55%)
Recruiting8 (40%)
Completed1 (5%)
not_applicable13 (65%)
Not Specified4 (20%)
Phase 21 (5%)
Phase 41 (5%)
Phase 31 (5%)